GL1X · GenesisL1 explorer

MolNFT v1 · #5105 · protein

One active site, two modes of reduction correlate the mechanism of leishmania pteridine reductase with pterin metabolism and antifolate drug resistance in trpanosomes

1E7W: “One active site, two modes of reduction correlate the mechanism of leishmania pteridine reductase with pterin…”. X-ray diffraction, 2 ligands (NDP, MTX), 5 pockets (best druggability 0.73). MolNFT v1 #5105 on GenesisL1: 3D…

PDB
1E7W
Type
protein
Length
525 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pteridine reductase
EC
1.1.1.253
UniProt
Q9U1F8
Ligands
NDP, MTX
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APteridine reductase (EC 1.1.1.253)protein26748% helix, 15% strandQ9U1F8
BPteridine reductase (EC 1.1.1.253)protein25848% helix, 17% strandQ9U1F8

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • MTX · Methotrexate · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15990.730.8048NDP, MTX, EDO
25870.720.8048NDP, MTX, EDO
32340.580.7931empty
4690.350.7822EDO
5500.260.7415empty

Interfaces

1 interface between chains.

  • A–B · 1898 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 1E7W · One active site, two modes of reduction correlate the mechanism of leishmania pteridine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.